PD-L1, a receptor for PD-1, is shown to be associated with acute myeloid leukemia via the activation of the PI3K-AKT pathway, apoptosis, and proliferation [52] and is marked as a potential target for the treatment of leukemia. Here, CD274 is linked to leukemia.